Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Bhatt, Deepak
Item TypeName
Academic Article Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE).
Academic Article Metformin use and mortality among patients with diabetes and atherothrombosis.
Academic Article Declining coronary artery bypass-related mortality: more than meets the eye?
Academic Article The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.
Academic Article Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
Academic Article Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
Academic Article Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
Academic Article Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus.
Concept Diabetes Mellitus, Type 1
Concept Diabetes Mellitus, Type 2
Academic Article Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
Academic Article Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.
Academic Article Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
Academic Article Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Academic Article Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
Academic Article Saxagliptin, alogliptin, and cardiovascular outcomes.
Academic Article Statin potency associated with incident diabetes in a real-world evaluation.
Academic Article Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
Academic Article Bariatric surgery versus intensive medical therapy for diabetes.
Academic Article Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptin.
Academic Article Ask the doctor. I've heard that taking statins can raise your risk of diabetes. Is this really true?
Academic Article Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.
Academic Article Do dipeptidyl peptidase-4 inhibitors increase the risk of heart failure?
Academic Article Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
Academic Article Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.
Academic Article Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials.
Academic Article Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.
Academic Article Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes.
Academic Article Impact of treatment with saxagliptin on glycaemic stability and ß-cell function in the SAVOR-TIMI 53 study.
Academic Article Yes, hyperglycaemia is indeed a modifiable cardiac risk factor: so says Mendel.
Academic Article Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.
Academic Article Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial".
Academic Article Medical management of peripheral artery disease in diabetes mellitus.
Academic Article Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.
Academic Article Response to: 'Baseline differences in SAVOR trial'-- prespecified vs. post hoc analysis--a potential source of bias.
Academic Article Troponin in Stable Ischemic Heart Disease and Diabetes.
Academic Article Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy.
Academic Article Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
Academic Article Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.
Academic Article Heart failure event definitions in drug trials in patients with type 2 diabetes.
Academic Article Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.
Academic Article Sex Differences in Cardiac Troponin and the Risk of Death or Major Cardiovascular Events.
Academic Article Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.
Academic Article Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.
Academic Article Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
Academic Article Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.
Academic Article Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
Academic Article Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years.
Academic Article Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial.
Academic Article Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
Academic Article Oral Antidiabetic Agents and Cardiovascular Outcomes.
Academic Article Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity.
Academic Article Increased Free Testosterone Levels in Men with Uncontrolled Type 2 Diabetes Five Years After Randomization to Bariatric Surgery.
Academic Article Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study.
Academic Article Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.
Academic Article Reply: Intersection of fasting plasma glucose, adverse cardiac remodeling, and clinical outcomes.
Academic Article Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.
Academic Article DECLARE-TIMI 58: Participants' baseline characteristics.
Academic Article Metabolic Surgery: Weight Loss, Diabetes, and Beyond.
Academic Article Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
Academic Article Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
Academic Article The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial.
Academic Article Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: translational implications.
Academic Article Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease.
Academic Article Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
Academic Article Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).
Academic Article The perils of polyvascular disease in type 2 diabetes.
Academic Article Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Academic Article SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Academic Article Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
Academic Article IMPACT OF WEIGHT LOSS TRAJECTORY FOLLOWING RANDOMIZATION TO BARIATRIC SURGERY ON LONG-TERM DIABETES GLYCEMIC AND CARDIOMETABOLIC PARAMETERS.
Academic Article Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.
Academic Article Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.
Academic Article Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Academic Article Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Academic Article Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.
Academic Article Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53.
Academic Article Vascular Regenerative Cell Exhaustion in Diabetes: Translational Opportunities to Mitigate Cardiometabolic Risk.
Academic Article A LEADER in the management of type 2 diabetes and cardiorenal disease.
Academic Article Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
Academic Article More CREDENCE for SGLT2 Inhibition.
Academic Article Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes.
Academic Article Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
Academic Article Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Academic Article Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
Academic Article SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes Mellitus.
Academic Article Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Academic Article Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
Academic Article Cardiometabolic risk reduction after metabolic surgery.
Academic Article THEMIS and THEMIS-PCI.
Academic Article Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.
Academic Article The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure.
Academic Article Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease.
Academic Article Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States.
Academic Article Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study.
Academic Article Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics.
Academic Article The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.
Academic Article Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
Academic Article Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk.
Academic Article Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes.
Academic Article Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
Academic Article Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
Academic Article Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
Academic Article The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study.
Academic Article The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trial.
Academic Article The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
Academic Article Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes Mellitus?
Search Criteria
  • Diabetes Mellitus Type 2
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.